Case Reports in Medicine (Jan 2016)

DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation

  • B. Dhakal,
  • A. D’Souza,
  • M. Pasquini,
  • W. Saber,
  • T. S. Fenske,
  • R. B. Moss,
  • W. R. Drobyski,
  • P. Hari,
  • M. Z. Abidi

DOI
https://doi.org/10.1155/2016/8503275
Journal volume & issue
Vol. 2016

Abstract

Read online

Parainfluenza virus (PIV) may cause life-threatening pneumonia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Currently, there are no proven effective therapies. We report the use of inhaled DAS181, a novel sialidase fusion protein, for treatment of PIV type 3 pneumonia in two allogeneic hematopoietic SCT recipients with respiratory failure.